Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia

Dekker, 1998, Etiology and pathogenesis of preeclampsia: current concepts, Am J Obstet Gynecol, 179, 1359, 10.1016/S0002-9378(98)70160-7 Roberts, 2002, Recent Insights into the pathogenesis of pre-eclampsia, Placenta, 23, 359, 10.1053/plac.2002.0819 Conrad, 1997, Placental cytokines and the pathogenesis of preeclampsia, Am J Reprod Immunol, 37, 240, 10.1111/j.1600-0897.1997.tb00222.x Hayman, 1999, Preeclampsia: the endothelium, circulating factor(s) and vascular endothelial growth factor, J Soc Gynecol Investig, 6, 3, 10.1016/S1071-5576(98)00044-6 Smarason, 1993, The effect of placental syncytiotrophoblast microvillous membranes from normal and pre-eclamptic women on the growth of endothelial cells in vitro, BJOG, 100, 943, 10.1111/j.1471-0528.1993.tb15114.x Redman, 1999, Preeclampsia: an excessive maternal inflammatory response to pregnancy, Am J Obstet Gynecol, 180, 499, 10.1016/S0002-9378(99)70239-5 Gervasi, 2001, Phenotypic and metabolic characteristics of monocytes and granulocytes in preeclampsia, Am J Obstet Gynecol, 185, 792, 10.1067/mob.2001.117311 Ferrara, 2003, The biology of VEGF and its receptors, Nat Med, 9, 669, 10.1038/nm0603-669 Gerber, 1998, Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway: requirement for Flk-1/KDR activation, J Biol Chem, 273, 30336, 10.1074/jbc.273.46.30336 Ostendorf, 1999, VEGF(165) mediates glomerular endothelial repair, J Clin Invest, 104, 913, 10.1172/JCI6740 Sugimoto, 2003, Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria, J Biol Chem, 278, 12605, 10.1074/jbc.C300012200 Kabbinavar, 2003, Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer, J Clin Oncol, 21, 60, 10.1200/JCO.2003.10.066 Maynard, 2003, Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia, J Clin Invest, 111, 649, 10.1172/JCI17189 Sibai, 1997, Risk factors associated with preeclampsia in healthy nulliparous women. The Calcium for Preeclampsia Prevention (CPEP) Study Group, Am J Obstet Gynecol, 177, 1003, 10.1016/S0002-9378(97)70004-8 Koga, 2003, Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia, J Clin Endocrinol Metab, 88, 2348, 10.1210/jc.2002-021942 Lyall, 1997, Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and in pre-eclampsia, BJOG, 104, 223, 10.1111/j.1471-0528.1997.tb11050.x Hornig, 2000, Release and complex formation of soluble VEGFR-1 from endothelial cells and biological fluids, Lab Invest, 80, 443, 10.1038/labinvest.3780050 Bosio, 2001, Maternal plasma vascular endothelial growth factor concentrations in normal and hypertensive pregnancies and their relationship to peripheral vascular resistance, Am J Obstet Gynecol, 184, 146, 10.1067/mob.2001.108342 Barleon, 2001, Soluble VEGFR-1 secreted by endothelial cells and monocytes is present in human serum and plasma from healthy donors, Angiogenesis, 4, 143, 10.1023/A:1012245307884 Charnock-Jones, 1994, Vascular endothelial growth factor receptor localization and activation in human trophoblast and choriocarcinoma cells, Biol Reprod, 51, 524, 10.1095/biolreprod51.3.524 Ahmed, 1995, Colocalisation of vascular endothelial growth factor and its Flt-1 receptor in human placenta, Growth Factors, 12, 235, 10.3109/08977199509036883 Clark, 1998, A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation, Biol Reprod, 59, 1540, 10.1095/biolreprod59.6.1540 Zhou, 2002, Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome, Am J Pathol, 160, 1405, 10.1016/S0002-9440(10)62567-9 Gerber, 1997, Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia, J Biol Chem, 272, 23659, 10.1074/jbc.272.38.23659 Shen, 1999, Vascular endothelial growth factor governs endothelial nitric-oxide synthase expression via a KDR/Flk-1 receptor and a protein kinase C signaling pathway, J Biol Chem, 274, 33057, 10.1074/jbc.274.46.33057